Anne Gonzales-Luna, PharmD

Articles by Anne Gonzales-Luna, PharmD

Image credit: Saiful52 - stock.adobe.com

Clinical Overview: Fecal Microbiota Transplantation vs Live Biotherapeutic Products for Management of Recurrent C Difficile Infection

ByAnne Gonzales-Luna, PharmD,Glenn S Tillotson PhD, FIDSA

September 15th 2023

Although antibiotics are the standard-of-care treatment for Clostridioides difficile infection, they can cause further microbiota changes that predispose patients to recurrence.

Anne Gonzales-Luna, PharmD

Articles by Anne Gonzales-Luna, PharmD

Clinical Overview: Fecal Microbiota Transplantation vs Live Biotherapeutic Products for Management of Recurrent C Difficile Infection

Latest Updated Articles

Trending on Pharmacy Times

A Common Virus May Hold New Clues to Lupus

Zongertinib Shows Clinically Meaningful Efficacy in Advanced HER2-Mutant NSCLC

Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals

SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer

When to Call, When to Counsel: Statin Drug Interactions